Safety-related drug attrition is still a major hurdle in the development of innovative pharmaceuticals. Therefore, an integrated safety assessment to identify On-/Off-target safety risk and de-risk the toxicity at an early drug discovery phase is an essential part of successful drug development. We Axcelead DDP can offer an ideal safety assessment strategy, mechanism-based and cost-effective solutions with high-quality and fast turnaround times, depending on your requirements and stage of your project. In this seminar, we will present our unique in vitro safety assessment services and risk mitigation solutions.